Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemiaRizwan Romee, Todd A. Fehniger, Arend Mulder et al.|Science Translational Medicine|2016Cited by 916
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Jeffrey S. Miller, Sarah Cooley et al.|Blood|2018Cited by 406
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia Wagner, Todd A. Fehniger, Maximillian Rosario et al.|Journal of Clinical Investigation|2017Cited by 311
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M. Berrien-Elliott, Todd A. Fehniger, Amanda F. Cashen et al.|Cancer Discovery|2020Cited by 146
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M. Berrien-Elliott, Todd A. Fehniger, Jennifer A. Foltz et al.|Science Translational Medicine|2022Cited by 119